Survival and repair durability in patients undergoing concomitant aortic valve reimplantation and mitral valve repair

Figures

• 

  The 10-year survival for concomitant AV reimplantation and MVr.

• 

  Figure 1. CONSORT-style diagram of patients undergoing concomitant AV reimplantation and MVr. AV, Aortic valve; MV, mitral valve; TV, Tricsupid valve; PV, pulmonary valve.

• 

  Figure 2. Longitudinal aortic regurgitation (AR) grades after concomitant AV reimplantation and MVr. Symbols represent data grouped (without regard to repeated measurements) within time frames to provide a crude verification of model fit. A, Postoperative prevalence of AR grades over time. Solid lines represent longitudinal trend in AR grades. Echocardiography follow-up: Shown are the number of patients remaining across follow-up years and number of follow-up echocardiograms within each yearly interval. B, Comparison of AR grades between patients with and without Marfan syndrome. Solid lines represent unadjusted estimates of prevalence of moderate or more AR grade over time, enclosed within a 68% confidence band. Echocardiography follow-up of the 2 cohorts: Shown are the number of patients remaining across follow-up years and number of follow-up echocardiograms within each yearly interval.

• 

  Figure 3. Longitudinal MR grades after concomitant AV reimplantation and MVr. Symbols represent data grouped (without regard to repeated measurements) within time frames to provide a crude verification of model fit. A, Postoperative prevalence of MR grades over time. Solid lines represent longitudinal trend in MR grades. Echocardiography follow-up: Shown are the number of patients remaining across follow-up years and number of follow-up echocardiograms within each yearly interval. B, Comparison of MR grades between patients with and without Marfan syndrome. Solid lines represent unadjusted estimates of prevalence of moderate or more MR grade over time, enclosed within a 68% confidence band. Echocardiography follow-up of the 2 cohorts: Shown are number of patients remaining across follow-up years and number of follow-up echocardiograms within each yearly interval.

• 

  Figure 4. Time-related reoperation on AV or MV after concomitant AV reimplantation and MVr. Each symbol represents a Kaplan–Meier estimate of the event, and vertical bars are 68% confidence limits equivalent to ± 1 SE. Numbers below horizontal axis are patients remaining at risk. A, Overall freedom from AV or MV reoperation. B, Comparison of freedom from AV or MV reoperation between patients with and without Marfan syndrome. MV, Mitral valve; AV, aortic valve.

• 

  Figure 5. Survival after concomitant AV reimplantation and MVr. Format as in Figure 4. A, Overall survival. B, Comparison of survival between patients with and without Marfan syndrome.